Showing promise in the arena of weight management management, retatrutide presents a different approach. Beyond many available medications, retatrutide functions as a double agonist, concurrently targeting both glucagon-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic hormone (GIP) sensors. The simultaneous engagement promotes various he